Genome-wide genetic data on ~500,000 UK Biobank participants (original) (raw)

New Results

, Colin Freeman, Desislava Petkova, Gavin Band, View ORCID ProfileLloyd T. Elliott, View ORCID ProfileKevin Sharp, View ORCID ProfileAllan Motyer, View ORCID ProfileDamjan Vukcevic, Olivier Delaneau, Jared O’Connell, Adrian Cortes, Samantha Welsh, Gil McVean, View ORCID ProfileStephen Leslie, Peter Donnelly, View ORCID ProfileJonathan Marchini

doi: https://doi.org/10.1101/166298

Abstract

The UK Biobank project is a large prospective cohort study of ~500,000 individuals from across the United Kingdom, aged between 40-69 at recruitment. A rich variety of phenotypic and health-related information is available on each participant, making the resource unprecedented in its size and scope. Here we describe the genome-wide genotype data (~805,000 markers) collected on all individuals in the cohort and its quality control procedures. Genotype data on this scale offers novel opportunities for assessing quality issues, although the wide range of ancestries of the individuals in the cohort also creates particular challenges. We also conducted a set of analyses that reveal properties of the genetic data – such as population structure and relatedness – that can be important for downstream analyses. In addition, we phased and imputed genotypes into the dataset, using computationally efficient methods combined with the Haplotype Reference Consortium (HRC) and UK10K haplotype resource. This increases the number of testable variants by over 100-fold to ~96 million variants. We also imputed classical allelic variation at 11 human leukocyte antigen (HLA) genes, and as a quality control check of this imputation, we replicate signals of known associations between HLA alleles and many common diseases. We describe tools that allow efficient genome-wide association studies (GWAS) of multiple traits and fast phenome-wide association studies (PheWAS), which work together with a new compressed file format that has been used to distribute the dataset. As a further check of the genotyped and imputed datasets, we performed a test-case genome-wide association scan on a well-studied human trait, standing height.

Footnotes

↵† These authors jointly directed this work.
1 Now part of Thermo Fisher Scientific.
2 The genotyping batches in the UK Biobank project contain ~4,700 samples, so a MAF of, for example, 0.001 corresponds to an expected count (under HWE) of about 9 heterozygotes per batch.